P2105-2111, SEPTEMBER 01, 2022
Paolo Cimaglia, Francesca Fortini, Francesco Vieceli Dalla Sega, Laura Sofia Cardelli, Rodolfo Francesco Massafra, Cristina Morelli, Michele Trichilo, Roberto Ferrari, Paola Rizzo, Gianluca Campo
Background and aims: While the role of PCSK9 in lipid metabolism is well established, its link with endothelial function is less clear. The aim of the present study is to evaluate the relationship between PCSK9 and endothelial dysfunction in the setting of acute myocardial infarction.
Methods and results: To this purpose, we analyzed the serum of 74 patients with ST-elevation myocardial infarction (STEMI) at the time of admission and after 5 days. Endothelial dysfunction was evaluated as rate of apoptosis (AR) of human umbilical vein endothelial cells incubated with patients’ serum. There was a good correlation between PCSK9 and the apoptosis rate values, both at baseline (r = 0.649) and 5-day (r = 0.648). In the 5 days after STEMI, PCSK9 increased significantly (242–327 ng/ml, p < 0.001), while AR did not (p = 0.491). Overall, 21 (28%) patients showed a reduction of PCSK9, and they had a significantly higher decrease of AR as compared to others (−13.87 vs 5.8%, p = 0.002). At the univariable analysis, the 5-day change of PCSK9 resulted to be the only variable associated with the 5-day change of the apoptosis rate (beta 0.217, 95%CI 0.091–0.344, p = 0.001).
Conclusion: The variation of endothelial function and PCKS9 in the first days after an acute myocardial infarction are related. Further validation and research are necessary to confirm our findings. Clinical trial NCT02438085.
Keywords: Endothelial function; PCSK9; Myocardial infarction
Read Full Text Here: https://www.nmcd-journal.com/article/S0939-4753(22)00285-X/fulltext